Francois Michelon, CEO of ENDRA Life Sciences (NASDAQ:NDRA) sat down with Proactive Investors at the 11th Annual LD Micro Main Event in Los Angeles. ENDRA is a developer of more sophisticated ultrasound technologies. The Michigan-based company's flagship product is a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS) platform to allow clinicians to visualize human tissue composition and function in ways once possible only with Cat scans and MRIs - at a fraction of the cost.
ENDRA Life Sciences has technology to take ultrasound to new heights
Quick facts: ENDRA Life Sciences inc
Price: 0.909 USD
Market Cap: $13.18 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE